In Vitro Colorectal Cancer Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027 | Abbott Laboratories, BioTime, Danaher Corporation, Epigenomics AG, Exact Sciences Corporation

The “In Vitro Colorectal Cancer Testing Market” report describes in detail the demand and consumption of various products/services related to the market growth dynamics during the forecast period of 2021-2027. A detailed market assessment of the various opportunities in the market segment is expressed in terms of quantity. These are discussed in many sections, including constraints, challenges and opportunities, regional breakdown and opportunity assessment. This global In Vitro Colorectal Cancer Testing Market report guarantees rich data on various market opportunities. The report includes strong research from expert analysts.

The In Vitro Colorectal Cancer Testing Market size is estimated to grow at a CAGR of 6.3% for 2021-2027.

SAMPLE REPORT LINK HERE:

https://www.marketintelligencedata.com/reports/803305/global-in-vitro-colorectal-cancer-testing-market-size-status-and-forecast-2021-2027/inquiry?mode=rukaiyya

This report covers introduce companies associated with the In Vitro Colorectal Cancer Testing Market:

Abbott Laboratories, BioTime, Danaher Corporation, Epigenomics AG, Exact Sciences Corporation, LifeLabs Medical Laboratory Services, Novigenix SA, Quest Diagnostics, Sysmex Corporation

Recent Development

Abbott Laboratories

Abbott Laboratories has acquired 36 companies, including 5 in the last 5 years. A total of 9 acquisitions came from private equity firms. It has also divested 8 assets. Abbott Laboratories’ largest acquisition to date was in 2016, when it acquired St. Jude Medical for $25.0B. It’s largest disclosed sale occurred in 2015, when it sold Abbott - Non-U.S. Developed Markets Specialty and Branded Generics to Viatris for $5.3B. Abbott Laboratories has acquired in 8 different US states, and 9 countries. The Company’s most targeted sectors include medical products (55%) and life science (34%).

Danaher Corporation

Danaher has acquired 44 companies, including 8 in the last 5 years. A total of 12 acquisitions came from private equity firms. It has also divested 9 assets. Danaher’s largest acquisition to date was in 2019, when it acquired GE Biopharma for $21.4B. It’s largest disclosed sale occurred in 2015, when it sold Danaher Corp - Communications Business to NetScout Systems for $2.3B. Danaher has acquired in 13 different US states, and 12 countries. The Company’s most targeted sectors include test/measurement equipment (22%) and medical products (20%).

Market segment by Type, covers

Fecal Occult Blood Tests
Stool Biomarkers Tests
Blood Biomarker Tests

Market segment by Application, covering

Ambulatory Surgical Centers
Hospitals
Physical Examination Center

GET REPORT LINK HERE:

https://www.marketintelligencedata.com/reports/803305/global-in-vitro-colorectal-cancer-testing-market-size-status-and-forecast-2021-2027?mode=rukaiyya

We will get up-to-date with you within 24hrs and assist you to notice the analysis reports and extra Customization you need.

North America Demand for In-vitro Colorectal Cancer Testing to Remain Highest

North America is expected to generate revenues of US$316.7 mn from in-vitro colorectal cancer screening testing. As per the findings released by the American Cancer Society, in 2015 more than 93,000 new cases of colon cancer and more than 39,000 cases of rectal cancer were diagnosed in the U.S. alone. The North American region also holds one of the largest population pools of elderly citizens, a demographic that is very prone to such diseases. These are the key reasons for the high demand for in-vitro colorectal cancer screening testing shown by the region. Meanwhile, the demand for in-vitro colorectal cancer screening testing is expected to increase at a very high rate in Europe, owing to the increasing number of the elderly and the growing availability of advanced and automated diagnostic tools and techniques.

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2021-2027) of the following regions are covered:

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of the Middle East & Africa)

BUY REPORT HERE:

https://www.marketintelligencedata.com/report/purchase/803305?mode=su?mode=rukaiyya

Some of the most significant insights gathered through the business intelligence study on the global In Vitro Colorectal Cancer Testing Market consists:

Key regions and leading countries in global In Vitro Colorectal Cancer Testing Market
Distribution network changes due to COVID19 pandemic
Key consumer segments are expected to drive global demand for the In Vitro Colorectal Cancer Testing market regional policy framework and regulatory guidelines.
Projected CAGR in the forecast period 2021 to 2027
Analysis of historical and current consumer buying trends related to the global In Vitro Colorectal Cancer Testing market.
Technological advancements and innovative products can completely change the In Vitro Colorectal Cancer Testing market.
Companies that held the leading share in the market during the historic years

Table of Contents: In Vitro Colorectal Cancer Testing Market

- Chapter 1: Outline of In Vitro Colorectal Cancer Testing Market

- Chapter 2: Global Market Status and Forecast by Regions

- Chapter 3: Global Market Status and Forecast by Types

- Chapter 4: Global Market Status and Forecast by Downstream Industry

- Chapter 5: Market Driving Factor Analysis

- Chapter 6: Market Competition Status by Major Manufacturers

- Chapter 7: Major Producers Presentation and market Information

- Chapter 8: Upstream and Downstream Market Investigation

- Chapter 9: Fetched and Net Edge Investigation

- Chapter 10: Marketing Status Investigation

- Chapter 11: Market Report Conclusion

- Chapter 12: Research Methodology and Reference

Impact of COVID-19 on the In Vitro Colorectal Cancer Testing Market:

The rise of COVID-19 has moderated showcase development; in any case, the market is continuously picking up pace due to rising lockdowns. The sudden increment in CAGR is due to the request and extension of this market, which is an ability to return to pre-pandemic levels once the widespread, is gone.

We conjointly supply customizations in reports supported specific client requirements:

The Global In-Vitro Colorectal Cancer Testing Market report is also changed to satisfy your specific business wants. As a result of we tend to perceive what our purchasers need, we provide the twenty-fifth customization for any of our middle reports at no further value to any or all or any of our purchasers.

Please contact our sales skilled (sales@marketintelligencedata.com ), we'll make sure you get the report that works for your wants.

About Us:

Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact Us:

Irfan Tamboli (Head of Sales) – MARKET INTELLIGENCE DATA

Phone: +1 (704) 266-3234

Mail to: sales@marketintelligencedata.com

This release was published on openPR.